+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

POC HbA1C Testing Global Market Opportunities and Strategies to 2030

  • ID: 5010748
  • Report
  • March 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • bioMerieux
  • Danaher Corporation
  • Diazyme Laboratories
  • EKF Diagnostics
POC HbA1C Testing Global Market Opportunities And Strategies To 2030 report from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global POC HbA1C Testing market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description:
Where is the largest and fastest growing market for the POC HbA1C testing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global POC HbA1C testing market report to 2030 report from the publisher answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – This section gives the segmentation of the POC HbA1C testing market by geography and segmentation by product, by technology and by end-user covered in this report.
  • Market Characteristics – The market characteristics section of the report defines and explains the POC HbA1C testing market. This chapter includes different devices covered in the report and basic definitions.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the POC HbA1C testing industry supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global POC HbA1C testing market.
  • Trends And Strategies – This chapter describes the major trends shaping the POC HbA1C testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Global Market Size And Growth – This section contains the global historic (2015 – 2019) and forecast (2019 – 2023, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Segmentation – This section contains the market values (2015 – 2023, 2025F, 2030F) and analysis for different segments in the market.
  • Regional Analysis – This section contains the historic (2015 – 2019), forecast (2019 – 2023, 2025F, 2030F) market value and growth and market share comparison by region.
  • Regional Market Size and Growth – This section contains the region’s market size (2019), historic and forecast (2015 – 2023, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global POC HbA1C testing market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations, currencies and research inquiries used in this report.

Markets Covered:
  • By Type Of Product: Consumables; Instruments
  • By Technology: Turbidimetric Inhibition Immunoassay; Affinity Binding Chromatography; Ion-Exchange HPLC; Enzymatic Assay; Others
  • By End-User: Physician Office/Outpatient Center; Home Care; Hospitals; Others

Companies Mentioned: Bio-Rad Laboratories, Inc.; Siemens Healthineers AG; Menarini Group; F. Hoffmann-La Roche Ltd.; ARKRAY Inc.

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • bioMerieux
  • Danaher Corporation
  • Diazyme Laboratories
  • EKF Diagnostics

1. POC HbA1C Testing Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Product
6.1.3. Segmentation By Technology
6.1.4. Segmentation By End User
7. POC HbA1C Testing Market Characteristics
7.1. Market Definition
7.2. POC HbA1C Testing Devices Market Segmentation
7.3. Segmentation By Type Of Product
7.3.1. Instruments
7.3.2. Consumables
7.4. Segmentation By Technology
7.4.1. Ion-Exchange HPLC
7.4.2. Enzymatic Assay
7.4.3. Affinity Binding Chromatography
7.4.4. Turbidimetric Inhibition Immunoassay
7.4.5. Others
7.5. Segmentation By End-User
7.5.1. Hospitals
7.5.2. Home Care
7.5.3. Others
8. POC HbA1C Testing Market Supply Chain Analysis And Key Participants9. POC HbA1C Testing Market Product Analysis – Product Examples
10. POC HbA1C Testing Market Customer Information
10.1. HbA1C Testing Is The Most Influenced Diagnostic Method
10.2. Low Compliance Among Americans For HbA1C Testing
10.3. HbA1C Testing Is One Of the Preferred Way For Sufferers To Gauge Their Current Level Of Diabetes
11. POC HbA1C Testing Market Trends And Strategies
11.1. Focus On Multi-Analyte Menus For Combined POC HbA1C Tests
11.2. Connectivity To EHRs Through Interoperability
11.3. Increasing Mergers and Acquisitions
11.4. Advances in Testing Technologies
11.5. Increasing Online Marketing Of POC Diagnostic Kits
11.6. Increasing Use Of Home HbA1C Testing Kits
12. Global POC HbA1C Testing Market Size And Growth
12.1. Market Size
12.2. Historic Market Growth, 2015 – 2019, Value ($ Million)
12.2.1. Drivers Of The Market 2015-2019
12.2.2. Restraints On The Market 2015-2019
12.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F, Value ($ Million)
12.3.1. Drivers Of The Market 2019-2023
12.3.2. Restraints On The Market 2019-2023
13. Global POC HbA1C Testing Market
13.1. Global POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.1.1. Consumables
13.1.2. Instruments
13.2. Global POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.2.1. Turbidimetric Inhibition Immunoassay technology
13.2.2. Affinity Binding Chromatography technology
13.2.3. Ion-Exchange HPLC technology
13.2.4. Other technology
13.2.5. Enzymatic Assay technology
13.3. Global POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
13.3.1. Physician Office/Outpatient Center end users
13.3.2. Home Care end users
13.3.3. Hospitals end users
13.3.4. Others end users
14. POC HbA1C Testing Market, Regional And Country Analysis
14.1. Global POC HbA1C Testing Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
14.2. Global POC HbA1C Testing Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15. Asia-Pacific POC HbA1C Testing Market
15.1. Asia Pacific POC HbA1C Testing Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulatory Bodies
15.1.6. Regulations
15.1.7. Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax
15.1.10. Investments
15.1.11. Major Companies
15.2. Asia-Pacific POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.2.1. Consumables
15.2.2. Instruments
15.3. Asia-Pacific POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.3.1. Turbidimetric Inhibition Immunoassay technology
15.3.2. Affinity Binding Chromatography technology
15.3.3. Ion-Exchange HPLC technology
15.3.4. Other technology
15.3.5. Enzymatic Assay technology
15.4. Asia-Pacific POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
15.4.1. Physician Office/Outpatient Center end users
15.4.2. Home Care end users
15.4.3. Hospitals end users
15.4.4. Other end users
16. China POC HbA1C Testing Market
16.1. China POC HbA1C Testing Market Overview
16.1.1. Country Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulatory Bodies
16.1.6. Regulations
16.1.7. Associations
16.1.8. Taxes Levied
16.1.9. Corporate Tax
16.1.10. Investments
16.1.11. Major Companies
16.2. China POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.2.1. Consumables
16.2.2. Instruments
16.3. China POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.3.1. Turbidimetric Inhibition Immunoassay technology
16.3.2. Affinity Binding Chromatography technology
16.3.3. Ion-Exchange HPLC technology
16.3.4. Other technology
16.3.5. Enzymatic Assay technology
16.4. China POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
16.4.1. Physician Office/Outpatient Center end users
16.4.2. Home Care end users
16.4.3. Hospitals end users
16.4.4. Other end users
17. India POC HbA1C Testing Market
17.1. India POC HbA1C Testing Market Overview
17.1.1. Country Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Associations
17.1.8. Taxes
17.1.9. Corporate tax
17.1.10. Investments
17.1.11. Major Companies
17.2. India POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.2.1. Consumables
17.2.2. Instruments
17.3. India POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.3.1. Turbidimetric Inhibition Immunoassay technology
17.3.2. Affinity Binding Chromatography technology
17.3.3. Ion-Exchange HPLC technology
17.4. India POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
17.4.1. Physician Office/Outpatient Center end users
17.4.2. Home Care end users
17.4.3. Hospitals end users
17.4.4. Other end users
18. Japan POC HbA1C Testing Market
18.1. Japan POC HbA1C Testing Market Overview
18.1.1. Country Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulatory Bodies
18.1.6. Associations
18.1.7. Taxes Levied
18.1.8. Corporate Tax
18.1.9. Investments
18.1.10. Major Companies
18.2. Japan POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.2.1. Consumables
18.2.2. Instruments
18.3. Japan POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.3.1. Turbidimetric Inhibition Immunoassay technology
18.3.2. Affinity Binding Chromatography technology
18.3.3. Ion-Exchange HPLC technology
18.3.4. Other technology
18.3.5. Enzymatic Assay technology
18.4. Japan POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
18.4.1. Physician Office/Outpatient Center end users
18.4.2. Home Care end users
18.4.3. Hospitals end users
18.4.4. Other end users
19. Australia POC HbA1C Testing Market
19.1. Australia POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.1.1. Consumables
19.1.2. Instruments
19.2. Australia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.2.1. Turbidimetric Inhibition Immunoassay technology
19.2.2. Affinity Binding Chromatography technology
19.2.3. Ion-Exchange HPLC technology
19.2.4. Other technology
19.2.5. Enzymatic Assay technology
19.3. Australia POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
19.3.1. Physician Office/Outpatient Center end users
19.3.2. Home Care end users
19.3.3. Hospitals end users
19.3.4. Other end users
20. Indonesia POC HbA1C Testing Market
20.1. Indonesia POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.2. Indonesia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.3. Indonesia POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
20.3.1. Physician Office/Outpatient Center end users
21. South Korea POC HbA1C Testing Market
21.1. South Korea POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.2. South Korea POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
21.3. South Korea POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22. Western Europe POC HbA1C Testing Market
22.1. Western Europe POC HbA1C Testing Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. Government Initiatives
22.1.5. Regulatory Bodies
22.1.6. Regulations
22.1.7. Associations
22.1.8. Taxes Levied
22.1.9. Corporate Tax
22.1.10. Investments
22.1.11. Major Companies
22.2. Western Europe POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.3. Western Europe POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.3.1. Turbidimetric Inhibition Immunoassay technology
22.3.2. Affinity Binding Chromatography technology
22.3.3. Ion-Exchange HPLC technology
22.4. Western Europe POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
22.4.1. Physician Office/Outpatient Center end users
23. UK POC HbA1C Testing Market
23.1. UK POC HbA1C Testing Market Overview
23.1.1. Country Information
23.1.2. Market Information
23.1.3. Background Information
23.1.4. Government Initiatives
23.1.5. Regulatory Bodies
23.1.6. Regulations
23.1.7. Associations
23.1.8. Taxes Levied
23.1.9. Corporate Tax
23.1.10. Investments
23.1.11. Major Companies
23.2. UK POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.3. UK POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
23.4. UK POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24. Germany POC HbA1C Testing Market
24.1. Germany POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.2. Germany POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
24.3. Germany POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
25. France POC HbA1C Testing Market
25.1. France POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
25.2. France POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
25.3. France POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
26. Eastern Europe POC HbA1C Testing Market
26.1. Eastern Europe POC HbA1C Testing Market Overview
26.1.1. Region Information
26.1.2. Market Information
26.1.3. Background Information
26.1.4. Government Initiatives
26.1.5. Regulatory Bodies
26.1.6. Regulations
26.1.7. Associations
26.1.8. Corporate Tax
26.1.9. Investments
26.1.10. Major Companies
26.2. Eastern Europe POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
26.3. Eastern Europe POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
26.4. Eastern Europe POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
27. Russia POC HbA1C Testing Market
27.1. Russia POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
27.2. Russia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
27.3. Russia POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
28. North America POC HbA1C Testing Market
28.1. North America POC HbA1C Testing Market Overview
28.1.1. Region Information
28.1.2. Market Information
28.1.3. Background Information
28.1.4. Government Initiatives
28.1.5. Regulations
28.1.6. Regulatory Bodies
28.1.7. Major Associations
28.1.8. Corporate Tax Structure
28.1.9. Investments
28.1.10. Taxes Levied
28.1.11. Major Companies
28.2. North America POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
28.2.1. Consumables
28.2.2. Instruments
28.3. North America POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
28.3.1. Turbidimetric Inhibition Immunoassay technology
28.3.2. Affinity Binding Chromatography technology
28.3.3. Ion-Exchange HPLC technology
28.3.4. Other technology
28.3.5. Enzymatic Assay technology
28.4. North America POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
28.4.1. Physician Office/Outpatient Center end users
28.4.2. Home Care end users
28.4.3. Hospitals end users
28.4.4. Others end users
29. USA POC HbA1C Testing Market
29.1. USA POC HbA1C Testing Market Overview
29.1.1. Country Information
29.1.2. Market Information
29.1.3. Background Information
29.1.4. Government Initiatives
29.1.5. Regulations
29.1.6. Regulatory Bodies
29.1.7. Major Associations
29.1.8. Corporate Tax Structure
29.1.9. Investments
29.1.10. Taxes Levied
29.1.11. Major Companies
29.2. USA POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
29.2.1. Consumables
29.2.2. Instruments
29.3. USA POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
29.3.1. Turbidimetric Inhibition Immunoassay technology
29.3.2. Affinity Binding Chromatography technology
29.3.3. Ion-Exchange HPLC technology
29.3.4. Other technology
29.3.5. Enzymatic Assay technology
29.4. USA POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
29.4.1. Physician Office/Outpatient Center end users
29.4.2. Home Care end users
29.4.3. Hospitals end users
29.4.4. Others end users
30. South America POC HbA1C Testing Market
30.1. South America POC HbA1C Testing Market Overview
30.1.1. Region Information
30.1.2. Market Information
30.1.3. Background Information
30.1.4. Government Initiatives
30.1.5. Regulations
30.1.6. Regulatory Bodies
30.1.7. Associations
30.1.8. Taxes Levied
30.1.9. Corporate Tax
30.1.10. Major Companies
30.2. South America POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
30.2.1. Consumables
30.2.2. Instruments
30.3. South America POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
30.3.1. Affinity Binding Chromatography technology
30.3.2. Ion-Exchange HPLC technology
30.3.3. Other technology
30.4. South America POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
30.4.1. Physician Office/Outpatient Center end users
30.4.2. Others end users
31. Brazil POC HbA1C Testing Market
31.1. Brazil POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
31.2. Brazil POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
31.3. Brazil POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
31.3.1. Others end users
32. Middle East POC HbA1C Testing Market
32.1. Middle East POC HbA1C Testing Market Overview
32.1.1. Region Information
32.1.2. Market Information
32.1.3. Background Information
32.1.4. Government Initiatives
32.1.5. Regulations
32.1.6. Regulatory Bodies
32.1.7. Associations
32.1.8. Corporate Tax
32.1.9. Major Companies
32.2. Middle East POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
32.3. Middle East POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
32.4. Middle East POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
33. Africa POC HbA1C Testing Market
33.1. Africa POC HbA1C Testing Market Overview
33.1.1. Region Information
33.1.2. Market Information
33.1.3. Background Information
33.1.4. Government Initiatives
33.1.5. Regulatory Bodies
33.1.6. Regulations
33.1.7. Associations
33.1.8. Taxes Levied
33.1.9. Corporate Tax
33.1.10. Investments
33.1.11. Major Companies
33.2. Africa POC HbA1C Testing Market, Segmentation By Product, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
33.2.1. Consumables
33.2.2. Instruments
33.3. Africa POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
33.3.1. Affinity Binding Chromatography technology
33.3.2. Turbidimetric Inhibition Immunoassay technology
33.3.3. Ion-Exchange HPLC technology
33.3.4. Other technology
33.3.5. Enzymatic Assay technology
33.4. Africa POC HbA1C Testing Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
33.4.1. Physician Office/Outpatient Center end users
33.4.2. Home Care end users
33.4.3. Hospitals end users
33.4.4. Others end users
34. Global POC HbA1C Testing Market Competitive Landscape
34.1. Company Profiles
34.2. Bio-Rad Laboratories, Inc.
34.2.1. Company Overview
34.2.2. Products And Services
34.2.3. Business Strategy
34.2.4. Financial Overview
34.3. Siemens Healthineers AG
34.3.1. Company Overview
34.3.2. Products And Services
34.3.3. Business Strategy
34.3.4. Financial Overview
34.4. Menarini Group
34.4.1. Company Overview
34.4.2. Products And Services
34.4.3. Business Strategy
34.4.4. Financial Overview
34.5. F. Hoffmann-La Roche Ltd.
34.5.1. Company Overview
34.5.2. Products And Services
34.5.3. Business Strategy
34.5.4. Financial Overview
34.6. ARKRAY Inc.
34.6.1. Company Overview
34.6.2. Products And Services
34.6.3. Business Strategy
34.6.4. Financial overview
35. POC HbA1C Testing Market, Key Mergers And Acquisitions
35.1.1. Tulip Diagnostics Pvt. Ltd Acquired Biosense Technologies Pvt. Ltd.
35.1.2. Edan Diagnostics, Inc. Acquired Molecular Diagnostics Point Of Care Platform From LGC
35.1.3. ArchiMed Acquired Eurolyser Diagnostica
35.1.4. Sinocare Inc. Acquired PTS Diagnostics
36. POC HbA1C Testing Market Future Outlook and Potential Analysis
36.1. Global POC HbA1C Testing Market In 2023 – Countries Offering Most New Opportunities
36.2. Global POC HbA1C Testing Market In 2023 – Product Segments Offering Most New Opportunities
36.3. Global POC HbA1C Testing Market In 2023 – Technology Segments Offering Most New Opportunities
36.4. Global POC HbA1C Testing Market In 2023 – End User Segments Offering Most New Opportunities
36.5. Global POC HbA1C Testing Market In 2023 – Growth Strategies
36.5.1. Market Trend Based Strategies
36.5.2. Competitor Strategies
37. Global POC HbA1C Testing Market Conclusions And Recommendations
37.1. Conclusions
37.2. Recommendations
37.2.1. Product
37.2.2. Place
37.2.3. Price
37.2.4. People
38. Appendix
38.1. Market Data Sources
38.2. NAICS Definitions Of Industry Covered In This Report
38.3. Currencies
38.4. Research Inquiries
38.5. About the publisher
39. Copyright and Disclaimer
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • bioMerieux
  • Danaher Corporation
  • Diazyme Laboratories
  • EKF Diagnostics
This report describes and evaluates the global POC HbA1C testing market. It covers two five-year periods, 2015 to 2019, termed the historic period, and 2019 through 2023, 2025F, and 2030F the forecast period.

The global POC HbA1C testing market reached a value of nearly $483.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.37% since 2015, and is expected to grow at a CAGR of 8.0% to nearly $658.6 million by 2023.

Growth in the historic period resulted from rise in diabetes prevalence, and increase in disposable income. Factors that negatively affected growth in the historic period were lack of awareness, and development of alternative blood glucose monitoring methods.

Going forward, favorable government initiatives, changing lifestyles, and rise in diabetic population will drive growth. Factors that could hinder the growth of the POC HbA1C testing market in the future include inability of testing devices to assess all blood types.

The POC HbA1C testing market is segmented by product into consumables, and instruments. The consumables market was the largest segment of the POC HbA1C testing market segmented by product, accounting for $316.31 million or 65.4% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.

The POC HbA1C testing market is segmented by technology into turbidimetric inhibition immunoassay, affinity binding chromatography, ion-exchange HPLC, enzymatic assay, and others. The turbidimetric inhibition immunoassay market was the largest segment of the POC HbA1C testing market, accounting for $222.01 million or 45.9% of the total in 2019 and affinity binding chromatography market is expected to be the fastest-growing segment going forward at a CAGR of 11.1%.

The POC HbA1C testing market is segmented by end user into physician office/outpatient center, home care, hospitals, and others. The physician office/outpatient center market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for $270.96 million or 56.0% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.

North America was the largest region in the POC HbA1C testing market, accounting for 41.5% of the global market in 2019. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest growing regions in the POC HbA1C testing market will be Eastern Europe and Asia Pacific, where growth will be at CAGRs of 12.4% and 10.4% respectively. These will be followed by Africa and Middle East, where the markets are expected to grow at CAGRs of 10.3% and 9.1% respectively.
The POC HbA1C testing market is highly concentrated, with a small number of players dominating the market. The top ten competitors in the market made up to 72.1% of the total market in 2019. Major players in the market include Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tosoh Bioscience, Danaher corporation Trinity Biotech plc, EKF Diagnostics Holdings plc, and Others.

The top opportunities in the POC HbA1C testing market segmented by product type will arise in the consumables segment which will gain $436.75 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the affinity binding chromatography segment which will gain $245.37 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment which will gain $374.28 million of global annual sales by 2023.

The POC HbA1C testing market size will gain the most in USA at $51.56 million. Market-trend-based strategies for the POC HbA1C testing market include developing and deploying technologies to capture and analyze data from the medical devices, M&A growth strategies to expand their customer base and geographic presence, online marketing strategies to expand their customer base and geographic presence. Player-adopted strategies in the POC HbA1C testing industry include expanding the diagnostics product portfolio and increase investments in R&D, expanding its business through collaborations, strengthening of its research and development network capability globally.

Diabetic patients are considered to have higher risk of suffering complications of COVID-19, therefore their usual treatment plans may change as communities and health services look to protect sufferers and follow social distancing measures and keep them home as much as possible. According to the World Health Organization (WHO), the most at-risk populations from corona virus are older people and individuals with pre-existing medical conditions such as high blood pressure, diabetes, heart disease, lung disease, and cancer. People with these conditions seem to develop more serious illness when they contract the virus. Both diabetes type 1 and 2 can increase risk of contraction. According to current Diabetes review, type 2 diabetes can increase the incidence of infectious diseases. According to other studies, Diabetes type 1 also increases risks for morbidity and mortality. In addition to that, according to the American Diabetes Association, in China, most cases occurred so far, people with diabetes had much higher rates of serious complications and death than people without diabetes. Therefore, POC HbA1C testing of diabetic patients is necessary due to COVID-19, so that they can seek to maintain and manage their condition at home, whilst limiting their potential exposure to the virus
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Aina Blood Monitoring Sysyem
  • Abbott Laboratories
  • Alere Inc.
  • bioMerieux
  • Danaher Corporation
  • Diazyme Laboratories
  • EKF Diagnostics
  • Getein Biotech, Inc
  • HemoCue
  • Instrumentation Laboratory
  • Nova Biomedical
  • Ortho Clinical Diagn
Note: Product cover images may vary from those shown

Loading
LOADING...